Conifer Holdings, Inc. (CNFR) - Q3 2024 10-Q Summary
Business Context and Reporting Period
This report covers the quarterly period ended September 30, 2024. Conifer Holdings, Inc. (the "Company") is an insurance holding company that has undergone a significant strategic transformation during the quarter. On August 30, 2024, the Company completed the sale of its wholesale agency business, Conifer Insurance Services ("CIS"), and its 50% interest in Sycamore Specialty Underwriters ("SSU"). These operations are now reported as discontinued operations. The Company has shifted from a model relying on agency commissions to one focused primarily on underwriting specialty homeowners insurance in Texas, Illinois, and Indiana, while running off its commercial lines business.
Key Financial Metrics
| Metric | Q3 2024 | Q3 2023 | 9M 2024 | 9M 2023 |
|---|---|---|---|---|
| Net Earned Premiums | $14.6M | $24.0M | $48.2M | $69.1M |
| Total Revenue (Continuing Ops) | $16.0M | $25.4M | $52.5M | $74.2M |
| Net Income (Loss) from Continuing Ops | $(6.9M) | $(4.4M) | $(9.0M) | $(7.9M) |
| Net Income from Discontinued Ops | $60.2M | $1.7M | $58.8M | $1.4M |
| Net Income (Loss) Total | $53.3M | $(2.7M) | $49.7M | $(6.4M) |
| Diluted EPS (Total) | $4.32 | $(0.22) | $4.00 | $(0.53) |
| Cash and Equivalents | $32.4M | $10.7M | $32.4M | $13.5M |
| Total Debt (Net) | $16.5M | $25.1M | $16.5M | $25.1M |
| Combined Ratio (Underwriting) | 143.1% | 120.8% | 120.0% | 114.1% |
Material Changes vs. Prior Period
- Discontinued Operations Gain: The primary driver of profitability was the sale of CIS and SSU, generating a total gain of approximately $61.2 million in Q3 2024. This contrasts sharply with Q3 2023, which had minimal discontinued operations income.
- Premium Volume Decline: Gross written premiums for continuing operations fell 60.9% year-over-year in Q3 2024 ($15.1M vs. $38.5M) due to the strategic exit from commercial lines and the sale of the agency business.
- Adverse Reserve Development: Continuing operations incurred $7.9 million in prior-year adverse loss development in Q3 2024, primarily driven by the Security Guard program (ceased writing in 2023). This contributed to a combined ratio of 143.1%.
- Debt Reduction: Proceeds from the CIS sale were used to pay off $9.3 million of Senior Secured Notes and redeem $6.0 million of Preferred Stock. Remaining debt consists of $17.9 million in 9.75% Senior Unsecured Notes due 2028.
- Liquidity Improvement: Cash and cash equivalents increased to $32.4 million from $10.7 million at the end of Q3 2023, bolstered by the asset sales.
Guidance, Outlook, and Risks
- Strategic Shift: The Company is transitioning to a smaller, underwriting-focused entity. It no longer has a wholesale agency business and relies heavily on two third-party agencies (CIS and SSU) for distribution, creating significant concentration risk.
- Regulatory Capital: Insurance subsidiaries (CIC and WPIC) previously fell below Risk-Based Capital (RBC) requirements. Management has submitted action plans to regulators, including ceasing writing in WPIC and significantly reducing volume in CIC. Additional capital contributions of $4.0M to $9.0M may be required before year-end.
- Rating Withdrawal: The Company withdrew from rating processes with A.M. Best and Kroll following downgrades to "C" and "B"/"BB-" respectively. This may impact the ability to attract business and reinsurance capacity.
- Contingent Consideration: The Company recorded $12.9 million in assets for contingent payments from the CIS sale. There is a significant risk that the $8.0 million portion related to future performance targets may not be realized.
- Internal Controls: Management identified a material weakness in internal controls related to the accounting for complex non-routine transactions (the CIS sale) due to the reduced size of the finance team.
Investor Verification Checklist
- Contingent Payment Realization: Verify the likelihood of receiving the $8.0 million in contingent consideration from the CIS sale, which is currently recorded as an asset but is subject to future performance hurdles.
- Regulatory Compliance: Monitor the status of the Insurance Company Subsidiaries' RBC ratios and confirm whether additional capital contributions are made to meet state regulatory requirements by year-end.
- Loss Reserve Adequacy: Assess the stability of loss reserves, particularly for the run-off commercial lines (Security Guard program), given the history of adverse development.
- Distribution Concentration: Evaluate the risks associated with relying on only two external agencies (CIS and SSU) for all premium production and billing.
- Nasdaq Compliance: Confirm continued compliance with Nasdaq listing requirements, specifically the minimum stockholders' equity and bid price rules, following the recent equity boost from the asset sales.